Literature DB >> 14726460

Theiler's virus infection: a model for multiple sclerosis.

Emilia L Oleszak1, J Robert Chang, Herman Friedman, Christos D Katsetos, Chris D Platsoucas.   

Abstract

Both genetic background and environmental factors, very probably viruses, appear to play a role in the etiology of multiple sclerosis (MS). Lessons from viral experimental models suggest that many different viruses may trigger inflammatory demyelinating diseases resembling MS. Theiler's virus, a picornavirus, induces in susceptible strains of mice early acute disease resembling encephalomyelitis followed by late chronic demyelinating disease, which is one of the best, if not the best, animal model for MS. During early acute disease the virus replicates in gray matter of the central nervous system but is eliminated to very low titers 2 weeks postinfection. Late chronic demyelinating disease becomes clinically apparent approximately 2 weeks later and is characterized by extensive demyelinating lesions and mononuclear cell infiltrates, progressive spinal cord atrophy, and axonal loss. Myelin damage is immunologically mediated, but it is not clear whether it is due to molecular mimicry or epitope spreading. Cytokines, nitric oxide/reactive nitrogen species, and costimulatory molecules are involved in the pathogenesis of both diseases. Close similarities between Theiler's virus-induced demyelinating disease in mice and MS in humans, include the following: major histocompatibility complex-dependent susceptibility; substantial similarities in neuropathology, including axonal damage and remyelination; and paucity of T-cell apoptosis in demyelinating disease. Both diseases are immunologically mediated. These common features emphasize the close similarities of Theiler's virus-induced demyelinating disease in mice and MS in humans.

Entities:  

Mesh:

Year:  2004        PMID: 14726460      PMCID: PMC321460          DOI: 10.1128/CMR.17.1.174-207.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  506 in total

1.  Purification of Theiler's murine encephalomyelitis virus and analysis of the structural virion polypeptides: correlation of the polypeptide profile with virulence.

Authors:  H L Lipton; A Friedmann
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

2.  The shiverer mutation affects the persistence of Theiler's virus in the central nervous system.

Authors:  F Bihl; C Pena-Rossi; J L Guénet; M Brahic; J F Bureau
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis.

Authors:  P D Murray; K Krivacic; A Chernosky; T Wei; R M Ransohoff; M Rodriguez
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

4.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 5.  Immunological memory and protective immunity: understanding their relation.

Authors:  R Ahmed; D Gray
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

6.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

7.  Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice.

Authors:  T P Leist; M Eppler; R M Zinkernagel
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

8.  Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro.

Authors:  B Mitrovic; L J Ignarro; S Montestruque; A Smoll; J E Merrill
Journal:  Neuroscience       Date:  1994-08       Impact factor: 3.590

9.  An isoelectric focusing overlay study of the humoral immune response in Theiler's virus demyelinating disease.

Authors:  R P Roos; E A Nalefski; S Nitayaphan; R Variakojis; K K Singh
Journal:  J Neuroimmunol       Date:  1987-01       Impact factor: 3.478

10.  Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice.

Authors:  S Trembleau; G Penna; E Bosi; A Mortara; M K Gately; L Adorini
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  112 in total

1.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

Review 2.  Gender differences in autoimmunity associated with exposure to environmental factors.

Authors:  K Michael Pollard
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

3.  The antiapoptotic protein Mcl-1 controls the type of cell death in Theiler's virus-infected BHK-21 cells.

Authors:  Sevim Yildiz Arslan; Kyung-No Son; Howard L Lipton
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

4.  Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis.

Authors:  Magdalena Janina Laska; Tomasz Brudek; Kari Konstantin Nissen; Tove Christensen; Anné Møller-Larsen; Thor Petersen; Bjørn Andersen Nexø
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

5.  Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release.

Authors:  E G Vichaya; E E Young; M A Frazier; J L Cook; C J Welsh; M W Meagher
Journal:  J Neuroimmunol       Date:  2011-10-13       Impact factor: 3.478

Review 6.  Neuroimmune interactions in a model of multiple sclerosis.

Authors:  C Jane Welsh; Andrew J Steelman; Wentao Mi; Colin R Young; Ralph Storts; Thomas H Welsh; Mary W Meagher
Journal:  Ann N Y Acad Sci       Date:  2009-02       Impact factor: 5.691

Review 7.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

8.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

9.  Phylogenetic analysis of the species Theilovirus: emerging murine and human pathogens.

Authors:  Zhiguo Liang; A S Manoj Kumar; Morris S Jones; Nick J Knowles; Howard L Lipton
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

10.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.